The OBN Investment & Tax Special Interest Group (ITSIG) works to get the voice of OBN Members heard in the national and local political arena in an effort to create a more favourable fiscal environment for emerging, small and medium sized enterprises in the life sciences industry, from UK and European Governments.
View the Group Objectives document here.
Please have a look and download 'From Seed to Unicorn', our guide to the sources of funding available to life sciences companies.
 |
The ITSIG Team
Chair:
Shawn Manning, Managing Director, Akesios Associates Limited
Members:
John Harris, CEO, OBN
Bill Fleming, Finance Consultant
Matthew Frohn, Partner, Longwall Ventures
Kathy Hills, Partner - Corporate, Penningtons Manches
Huw Jones, CEO, Evgen Pharma PLC
Graham Samuel-Gibbon, Partner, Taylor Wessing
Mike Shearan, Senior Tax Manager, James Cowper Kreston
Howard Sherman, CFO, Safeguard Biosystems Holdings Ltd
